Global Endoluminal Suturing Devices Market Size By Product Type (Single-Use, Reusable), By Application (Bariatric Surgery, Gastrointestinal (GI) Surgery), By End-Use (Hospitals, Ambulatory Surgical Centers), By Geographic Scope And Forecast

Endoluminal Suturing Devices Market Size And Forecast

Endoluminal Suturing Devices Market size was valued at USD 75.6 Million in 2022 and is projected to reach USD 177.06 Million by 2030, growing at a CAGR of 11% from 2023 to 2030.

The market’s rapid expansion is mostly due to factors such as rising obesity rates and a growing desire for minimally invasive weight loss operations. Obesity is a serious health risk and the second leading cause of mortality in the United States. According to the Centres for Disease Control and Prevention (CDC), the prevalence of obesity in the United States was 42.4% in 2018, with severe obesity accounting for 9.2% of people. Endoluminal surgery is a minimally invasive operation conducted in a hollow organ utilising suturing and stapling procedures. The growing popularity of these operations is mostly due to increased knowledge of less invasive methods and a reduction in post-operative complications.

Global Endoluminal Suturing Devices Market Definition

Endoluminal suturing devices are medical devices that are used to seal or repair tissue within the body. They are intended to be introduced through a tiny incision in the body and are often utilised in minimally invasive operations such as laparoscopic or endoscopic procedures. Endoluminal suturing devices are made up of three partsa handle, a suture needle, and suture material. The device is controlled by the handle, while the needle penetrates the tissue and the suture material closes the incision. Endoluminal suturing devices are advantageous because they enable surgeons to execute complicated procedures with little invasiveness, resulting in less discomfort and quicker patient recovery periods.

Global Endoluminal Suturing Devices Market Overview

The rising obese population and chronic illnesses resulting in patient pools, as well as the increasing desire for minimally invasive operations, are the primary drivers driving the worldwide growth of the Endoluminal Suturing Devices Market. Obesity has become a global pandemic, posing a serious health risk as well as being the second most avoidable cause of death in the United States. According to the Centres for Disease Control and Prevention (CDC), the obese population in the United States was 42% in 2018, with individuals suffering from severe obesity accounting for 9.2%.

Endoluminal surgery meets the desire of patients for less invasive procedures conducted in a hollow organ employing suturing and stapling surgical methods. Endoluminal operations are becoming more popular as people become more aware of the benefits of less invasive treatments and the reduction in post-surgical problems. These reasons will help to explain the growth of the market for endoluminal suturing devices. Other factors driving market growth include an increase in the number of suturing operations, an increase in the elderly population, and technological advancements in the manufacture of suturing equipment.

However, the lack of dexterity in these devices, as well as various functional restrictions, have a detrimental influence on the endoluminal suturing devices industry, stifling growth. The market is further complicated by the fact that enhanced wound-sealing substances such as fibrin, glues, and medical adhesives constitute a significant challenge to these devices on the market. These substances are chosen by surgeons and healthcare workers because to their benefits such as ease of application, less blood loss, a faster healing process, and improved clinical outcomes. Furthermore, one of the sections of the United States Patient Protection and Affordable Care Act (PPACA) that imposes a 2.3% excise tax on medical equipment proves to be a global restraint for this industry.

Endoluminal suturing robotics have been established to address issues such as the use of endoluminal suturing devices in confined places, error reduction, and robotic surgery also allows the surgeon to imitate human wrist movement. Furthermore, the use of robotics allows the surgeon to have some mobility with the robotic arm and greater control of three-dimensional vision.

Global Endoluminal Suturing Devices MarketSegmentation Analysis

The Global Endoluminal Suturing Devices Market is Segmented on the basis of Product Type, End-use, Application, and Geography.

Endoluminal Suturing Devices Market, By Product Type

• Single-Use
• Reusable

Based on Product Type, the market is segmented into Single-Use and Reusable. In 2022, the single-use category will account for the majority of revenue in the worldwide Endoluminal Suturing Devices Market. This is related to an increase in the need for minimally invasive surgeries, the incidence of GI illnesses, and the preference for disposable medical equipment. Single-use devices have several advantages, including less cross-contamination, increased safety, and convenience of handling and storage.

Furthermore, these instruments do not require sterilisation or maintenance, which reduces the overall cost of operation. During the forecast period, the reusable category is predicted to have a consistently rapid revenue growth rate in the worldwide Endoluminal Suturing Devices Market. This is owing to a greater emphasis on sustainability and environmental responsibility, as well as cost-effectiveness and technical advancements in the manufacturing process.

Endoluminal Suturing Devices Market, By Application

• Bariatric Surgery
• Gastrointestinal (GI) Surgery
• Others

Based on Application, the market is segmented into Bariatric Surgery, Gastrointestinal (GI) Surgery, Others. In 2022, the gastrointestinal surgery category had the highest revenue growth rate in the worldwide Endoluminal Suturing Devices Market. This is owing to an increase in the prevalence of GI illnesses such as Gastroesophageal Reflux Disease (GERD), Inflammatory Bowel Disease (IBD), and Colorectal Cancer, as well as an increase in the demand for Minimally Invasive Surgeries (MIS).

Endoluminal suturing devices are used in gastrointestinal operations to suture and seal perforations, create anastomoses, and mend fistulas. Furthermore, these technologies provide many benefits such as shorter surgery times, shorter hospital stays, and faster recovery. During the forecast period, the bariatric surgery segment is estimated to account for a sizable revenue share of the worldwide Endoluminal Suturing Devices Market. This is owing to the rising incidence of obesity and its associated comorbidities, which include type 2 diabetes, hypertension, and cardiovascular disease.

Endoluminal Suturing Devices Market, By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

Based on the End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Others. The hospitals category has the greatest market share and is expected to maintain its dominance during the projection period. This is attributable to the rising prevalence of chronic illness and the increased frequency of bariatric procedures. Furthermore, increased patient pool and improved healthcare infrastructure are supporting the growth of the market for endoluminal suturing devices. Furthermore, the presence of trained healthcare professionals in developed nations such as the United States, as well as increased private and government healthcare spending, is propelling the Endoluminal Suturing Devices Market. Because of the rising number of minimally invasive operations that restrict hospital stay, the ambulatory surgical centres category is developing at the quickest rate.

Endoluminal Suturing Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Based on Regional Analysis, the Endoluminal Suturing Devices Market is classified into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America led the market for endoluminal suturing devices. This is due to the availability of a big patient pool and favourable reimbursement rules. The growing number of bariatric operations is likely to have a direct beneficial influence on the growth of the market for endoluminal suturing devices. The Asia Pacific market for endoluminal suturing devices is predicted to develop at the quickest rate due to improved healthcare infrastructure and the existence of a large population prone to different chronic illnesses.

Key Players

The “Global Endoluminal Suturing Devices Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as Teleflex Incorporated, Apollo Endosurgery, Inc., Medtronic plc., Boston Scientific Corporation, Olympus Corporation, Cook Medical, EndoEvolution, LLC, Ethicon US, LLC (a subsidiary of Johnson & Johnson), Sewa Medicals Limited.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• In July 2022, Medtronic, a leading medical technology company, and the American Society for Gastrointestinal Endoscopy have announced plans to expand the Medtronic-Health-Equity-Assistance-Program for colon cancer screening across the United States with the help of Amazon Web Services’ (AWS) Health Equity Initiative.
• In May 2022, Aesculap and True Digital Surgery reinforced their long-term collaboration in robotically-controlled-3D-digital visualization by establishing a new distribution agreement. Aesculap has officially awarded the Aesculap Aeos electronic surgical microscope long-term exclusive distribution rights. A deal was struck between Aesculap AG and True Digital Surgery, Inc.
• In January 2022, Endo Tools Therapeutics (ETT), a provider of complex endoscopic medical devices for gastroenterologists, announced the FDA 510(k) approval of the domina system, which was designed for endoscopic suture application and soft tissue approximation in the gastrointestinal tract on adults. A global triangulation platform with a tissue piercing and approximation device comprises the domina system.
• In September 2021, Boston Scientific Corporation purchased Devoro Medical, a company specializing in the development of minimally invasive technologies for the treatment of different GI illnesses. Boston Scientific will be able to increase its product portfolio as a result of this purchase, providing clinicians with more treatment options.
• In June 2021, Ethicon, a Johnson & Johnson subsidiary and a leader in flexible endoluminal robotics and soft tissue microwave ablation, stated that the National Institute for Health and Care Excellence (NICE) new medical technology guidelines has endorsed the use of its Plus Sutures.
• In February 2020, Medtronic plc. acquired Digital Surgery, a company that specialises in the development of digital tools for surgical teaching and training. Medtronic will be able to expand its surgical solution portfolio while providing clinicians with cutting-edge training and instructional resources as a result of this purchase.
• In December 2020, Reshape Lifesciences has acquired Apollo Endo-surgery, Inc.’s surgical product line laparoscopic bariatric surgery. This will expand Apollo’s Endo-bariatric product line.

Ace Matrix Analysis

The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of services, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.

Market Attractiveness

The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Endoluminal Suturing Devices Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.

Porter’s Five Forces

The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. The porter’s five forces model can be used to assess the competitive landscape in global Endoluminal Suturing Devices Market gauge the attractiveness of a certain sector, and assess investment possibilities.

Report Scope